The IL-17A-deficient mice or blockade of IL-17A with neutralizing antibody ameliorated renal dysfunction and protected against progression in DKD mice by inhibiting the renal inflammatory response [18, 19]. This evidence concerns the gene IL17A and diabetic kidney disease.